Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Mini Review
Original Article
Research Article
Review Article
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Mini Review
Original Article
Research Article
Review Article
View/Download PDF

Translate this page into:

Review Article
ARTICLE IN PRESS
doi:
10.25259/JQUS_2_2025

Anticancer Potential of Calotropis procera: A Contemporary Update Review

Department of Chemistry, College of Science, Qassim University, Buraydah, Qassim, Kingdom of Saudi Arabia
Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah, Qassim, Kingdom of Saudi Arabia.

* Corresponding author: Prof. Dr. Lotfi Mohamed Aroua, Department of Chemistry, College of Science, Qassim University, Burayda, Qassim, Kingdom of Saudi Arabia. aroua.lotfi@yahoo.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Alharbi SO, Mohammed HA, Aroua LMM. Anticancer Potential of Calotropis procera: A Contemporary Update Review. J Qassim Univ Sci. doi: 10.25259/JQUS_2_2025

Abstract

Calotropis procera (Aiton) Dryand. is an herbal remedy that has been known for various traditional uses. Its diverse content of biologically potent compounds includes tannins, flavonoids, steroids, cardenolides, alkaloids, terpenoids, and enzymes. The rich composition has prompted extensive research on the antitumor properties against an array of malignant cell lines. The research outcomes reveal a promising potential in different cell lines. Multiple components of the shrub, including stems, roots, leaves, flowers, and aerial parts, showed anticancer properties against sarcoma 180, human colon cancer in both types HCT-8 and HCT-116, breast MDA-MB-435, breast MCF-7, brain SF-295, human leukemia HL-60, and ovarian OVCAR-8 malignant cell lines. Several anticancer compounds are present in the shrub, including calotoxin, calotropin, uscharin, calactoprocin, proceraside A, methyl ferulate, and frugoside. Both in vivo and in vitro studies have revealed marked cytotoxicity, in some cases comparable with the effect of standard anticancer drugs. Despite the claimed anticancer activity of the shrub, the toxicity of its extracts includes salivation, stomatitis, emesis, diarrhea, mydriasis, tetanic convulsions, collapse, and in some cases death. Therefore, thorough research to examine the toxic effects of the shrub and its extracts on humans is an essential step to guarantee that it is safe for humans and facilitate the process to develop anticancer drugs based on this important medicinal shrub. Moreover, the novel topic of nanoparticles derived from Calotropis procera is emerging with promising results and should be explored for use as anticancer drugs or as drug-delivery agents.

Keywords

Anticancer activity
Calotropis procera
Cytotoxic
Inhibition
Medicinal plants

INTRODUCTION

Cancer is second only to cardiovascular illnesses in terms of the main causes of mortality in the whole population.[1] Assessments suggest that a fifth of all people will develop malignancy at some phase of their entire life, whereas one out of nine males and one out of twelve females will succumb due the causes of the disease.[2] The cases of early occurrence of malignancy leading to death are growing internationally. Showing major variations in mortality, disability-adjusted life years over regions, nations, genders, and cancer types.[3] The prevalent malignancy types globally include the lip, buccal cavity, breast, thyroid, and cervical cancers. Nonetheless, less common malignancies include bone tumors such as osteosarcoma and Ewing's sarcoma, male breast carcinoma, malignant mesothelioma, gastrointestinal soft tissue neoplasms, chondrodrosarcoma, adrenocortical carcinoma, cholangiocarcinoma, kidney chromophobe carcinoma, pheochromocytoma, paraganglioma, sarcoma, and ependymal tumors, which accounted for more than fifth of malignancy incidences which made them be categorized in the less common cancer shapes.[4] Numerous dietary regimens have been linked to an elevated risk of developing cancer, particularly those high in processed meats, refined carbohydrates, and unhealthy fats.[5]

Herbal remedies are one of the major sources of various anticancer agents that have been used in drugs currently in use. Secondary metabolites, which are known as biologically effective chemicals, are essential for anticancer therapy.[6] Numerous compounds from natural sources are being tested in the laboratory and human experiments to explore their possible therapeutic applications as drugs, such as their possible activity in fighting cancer, inhibiting inflammation, and suppressing free radicals.[7] Compounds from natural origin, including alkaloids (matrine, berberine, and piperine), terpenoids (andrographolide, artesunate, and atractylodes), flavonoids (quercetin, tanshensin IIa, and icariin), phenol compounds (curcumin, quercetin, resveratrol, and capsaicin), and others, are considered vital substances. They boost immunological responses, promote cell death, prevent invasion and metastasis, and have anti-inflammatory properties. These natural compounds have exhibited effectiveness against multiple malignancies, including lung, breast, and ovarian cancer.[7,8] A recent study indicates that 32% of all small molecular weight compound medications authorized from 1981 to 2019 are derived from natural sources.[9] Calotropis procera is a herbal remedy that has demonstrated probable bioactivity, particularly against malignancy.[10] The herb belongs to the Asclepiadaceae family and is known for its significant biological properties.[11] Calotropis procera is widespread in West Africa, Asia, and various equatorial regions.[12] The plant has incredible growth ability; it can thrive in several soil types and tolerate harsh weather conditions such as salinity, drought, and high electromagnetic waves. Therefore, it is a widely spread plant across arid and semi-arid regions.[13] The phytochemical composition of the plant is described [Figure 1] as a diverse content of flavonoids, saponins, tannins, terpenoids, steroids, alkaloids, and cardenolides according to studies.[14-16] The mentioned categories of compounds are prominent for their pharmacological properties including anticancer and inflammation agents, pain relivers, and as hepatoprotectants.[17] The phytochemical content of Calotropis procera contain also flavonoids according the literature.[18,19] The aim of this article is to provide a comprehensive review of the current knowledge of Calotropis procera anticancer properties and determine the gap and prospects of the plant in developing new cancer therapeutics.

Calotropis procera from Qassim region, Saudi Arabia.
Figure 1:
Calotropis procera from Qassim region, Saudi Arabia.

BOTANICAL ACCOUNT

A summary of the botanical description and characteristic features of Calotropis procera has been documented in Table 1.

Table 1: Botanical properties of Calotropis procera
Part Description Ref
Plant Tall evergreen herb reaching up to 6 m in height [14]
Stems Greyish-green, sleek, mature stems have a deeply fissured bark [13]
Leaves Large, pale green, opposite phyllotaxy [18]
Flowers Contain triangular sepals. Flowers have a white base and violet edges [13]
Fruit Grassy, porous, rounded shape of 8-14 cm long by 6-9 cm wide. [13]
Seeds Brown, with a pappus of white filaments [13]
Harvesting Attainable in all seasons, with the ability to be collected three times annually. [19]

Calotropis procera is a semi-woody, perennial herb belonging to the family Apocynaceae and the subfamily Asclepiadaceae. It is a plant with a strong ability to tolerate harsh environments typically found in dry and semi-arid environments.[14]

METHODOLOGY

A comprehensive literature search was conducted. Using PMC, ScienceDirect, Springer, Google Scholar, and ResearchGate to collect articles on the anticancer activity of Calotropis procera. Some of the key words used were “Calotropis procera,” “anticancer,” and “cytotoxic activity,” with no time restriction. Original and review articles were included, provided that they focus explicitly on Calotropis procera. Articles conducted on other species, such as Calotropis gigantea, were excluded. The last search was conducted on 7 June 2025. Relevant data from in vivo and in vitro studies on plant parts, extracts, compounds, tested cancer cell lines, Inhibitory Concentration 50 (IC₅₀) values, and mechanisms of action were collected and used to produce a comprehensive overview.

ANTICANCER ACTIVITY

All parts of Calotropis procera root bark, leaves, flowers, fruits, and seeds exhibited cytotoxic potential in numerous studies.[20-23]

Root and root bark

The antitumor effects of water extract from the root bark of Calotropis procera against tumor cell lines were examined. The results indicated that the extract demonstrated cytotoxicity towards human colon adenocarcinoma Caco-2 and mouse neuroblastoma Neuro-2a cell lines. Moreover, the DNA fragmentation assay conducted on Caco-2 cell lines displayed DNA blurring, indicating nuclear material loss resulting in possible genetic toxicity.[24]

A number of substances were isolated and tested for anticancer activity against prostate PC-3 cancer cell lines, glioblastoma U373, and non-small cell lung cancer A549 in a study on the root bark of Calotropis procera. Calotroposide K and Calotroposide M, two of the extracted compounds, hindered the growth of prostate PC-3 and glioblastoma U373 cancer cell lines.[25] Nonetheless, the study did not state whether the inhibition effect was selective to the mentioned cancer cells or also harmed the normal cells, which is a critical factor in adapting these compounds for therapeutic uses.

Protein derived from the root bark of Calotropis procera was evaluated for cytotoxic properties in an in vitro and in vivo study. The results revealed that the protein suppressed growth and triggered programmed cell death of breast cancer cells by preventing the activity of nuclear regulator kappa B (NF-kB). Also, the set of rats receiving Calotropis procera protein had a strong elevation in vitamin C, potentially clarifying its potential anticancer characteristics.[26]

The antitumor effect of the ethanolic extract of Calotropis procera roots against the canine mammary cancer CF41-Mg cell line. The extract exhibited remarkable cytotoxicity and triggered apoptosis. Consequently, Calotropis procera roots are considered a promising choice for anticancer therapy[27]

Roots of Calotropis procera were extracted using ethanol. The extract was then fractioned into several fractions of chloroform, ethyl acetate, and water to evaluate the anticancer activity of these fractions on Artemia salina in an in vitro study. Ethyl and hexane extracts had the most cytotoxic activity of all fractions.[28]

The roots of Calotropis procera were extracted using 95% alcoholic solvent. The extract was then evaluated for its antioxidant and anticancer effects on human prostate DU145 and breast MCF-7 cancer cells. The root extract of Calotropis procera exhibited the most inhibitory effect on both cell lines. The Soxhlet ethanolic extract of Calotropis procera showed significant apoptosis against breast MCF-7 and prostate DU145 cancer cell lines.[29]

Another study was conducted to evaluate the growth inhibition activity of alcoholic, hydro-aqueous, and water extracts and extract separations of Calotropis procera roots on human oral KB and central nervous system (CNS) SNB-78 cancer cell lines. The outcomes of the study revealed that alcoholic extract inhibition activity was the most superior extract, On the other hand, the chloform and n-butanol fractions of the alchoholic extract shown antiproliferative effect on oral human oral cancer (KB) and brain central nervous system (CNS) cancer cell lines, respectively.[30]

Stem

Various organic solvents were used to extract the stems of Calotropis procera. All extracts were investigated for cytotoxic effect in an in vitro cell lines and in vivo samples of mice with sarcoma. Ethyl acetate and acetone from all extracts were found to be most potent against multiple cell lines, such as human leukemia HL-60, murine melanoma BF16-10, and human colon cancer HCT-8. The inhibition potency was confirmed by the IC50, which ranged from as low as 0.8 to 4.4 µg/mL across the tested cells. On the other hand, sarcoma 180-induced rats showed significant inhibition of the malignant cells after treatment with ethyl acetate and acetone extracts for a week. It was concluded that both extracts possess significant anticancer properties in both types of trials.[31]

Latex

The milky sap of Calotropis procera is rich in anticancer compounds, both in pure and isolated forms. Among those compounds with cytotoxic activity are cardenolides, steroids, flavonoids, triterpenoids, and proteins, with various chitinase isoforms present in the latex.[32]

The milky sap-derived proteins of Calotropis procera were evaluated for anticancer activity on induced sarcoma 180 in mice. The laticifer proteins have exhibited an inhibition effect of approximately 50%, prolonging the life of the mice by four days. The study revealed that proteins extracted from the milky sap of the shrub exhibited pharmacological ability to modulate cancer cell growth.[33]

The milky sap of Calotropis procera was used to extract laticifer proteins. The isolated proteins were then tested against an array of malignant cell lines, including promyelocytic HL-60, bowel HCT-8, human breast MDA-MB-435, and brain SF295 cancer cell lines, in an in vitro study. The isolated latex proteins were found to show strong cytotoxic effects. Values of IC50 varied between 0.42 and 1.36 μg/mL, confirming the activity of these isolated species against cancerous cells. Notably, the latex-isolated proteins showed preferential toxicity on malignant cells with minimal harm on normal cells. Nonetheless, the need for in vivo studies, which is ongoing, is critical to support the cytotoxic effect of the proteins further.[22] Nonetheless, in vivo confirming studies of these findings are a critical step before utilizing the proteins in human trials, given the known toxicity of the milky sap of Calotropis procera. Until proven under in vivo conditions, the potential of these derived proteins as an anticancer agent remains unestablished.

The milky sap of Calotropis procera was fractioned into several organic fractions. The fractions were then investigated for anticancer activity on leukemia HL-69, colon cancer HCT-116, ovarian malignancy Ovcar-8, and glioblastoma SF-295 cell lines. Of the organic portions used in this study, hexane and ethyl acetate had the most anticancer activity against all malignant cell lines tested. The IC50 values reported according to the study varied between 0.05 and 6.5 µg/mL.[34]

Another study used the latex from Calotropis procera to isolate cardiac glycosides and tested them on the breast MCF-7 cancer cell line. The latex extract restrained MCF-7 cells from growing significantly, and the effect increased in a direct relationship with concentration. Also, there was an increase in the levels of reactive oxygen species (ROS) inside cells, which is thought to be caused by the extract of cardiac glycosides. The extract of cardiac glycosides caused MCF-7 cells to die, endure programmed cell death, and autophagy.[35]

The milky sap of Calotropis procera was utilized to extract an alkaloid called T-undecalactone. The compound exhibited cytotoxic activity, and the cytotoxic effect of T-undecalactone increased proportionally with the concentration against oral and oesophageal cell cancer.[36]

Methanolic extract of Calotropis procera latex was evaluated against bowel cancer. The treatment with dried latex extract resulted in normalization of levels of glutathione, superoxide dismutase, nitrite, myeloperoxidase, prostaglandin E2, tumor nercosis factor α (TNF-a), and interleukin-1 beta in the rats diagnosed with bowel cancer.[37]

The milky sap of Calotropis procera was used to isolate enzymes specifically chitinase enzymes in a study. The enzymes were evaluated for anticancer activity on colon cancer HCT-116, ovarian cancer OVCAR-8, and brain cancer SF-295 cell lines. The study observed that the chitinase enzyme LPp1-P4 kept all anticancer activities of LPp1 against cancer cell lines, which was notable in IC50 found in values ranging between 1.2 μg/mL and 2.9 μg/mL. A conclusion was reached that chitinase enzyme isoforms LPp1-P4 isolated from the plant possess significant anticancer properties against cancerous cells.[38]

One of the cardenolides present in the milky sap of Calotropis procera has shown significant properties in fighting cancer cells, including brain, breast, lung, liver, and colon cancer cells.[39]

Leaves

The methanol extract of Calotropis procera leaf was evaluated to assess its extractability in fighting breast cancer in MCF-7 breast cancer cells. The extract has been found to exhibit a significant cytotoxic effect on breast cancer cell lines.[40]

One of the constituents of Calotropis procera leaves was isolated and found to be colchicine. The isolated compound was evaluated for its anticancer activity on different cell lines, namely breast MCF-7 and human esophageal cancer cell lines. The extracted compound exhibited marked activity on both MCF-7 and human esophageal carcinoma SK-GT-4 cell lines with values of IC50 of 55.33 µg/mL and 522 µg/mL respectively.[41]

Gold nanoparticles produced from Calotropis procera leaves extract were assessed for cytotoxic activities against MCF-7 cell lines. The generated gold nanoparticles turned the cells less viable, with an IC50 value of 0.312 µg/mL.[42]

The methanolic extract of the leaves of Calotropis procera was evaluated for cytotoxic effect on breast MCF-7 cancer cell lines. It was concluded that the alcoholic leaves extracts showed antiproliferative properties on breast MCF-7 cancer cells. Also, the leaves extract showed a potent antibacterial effect.[20,43]

The extract was then evaluated for anticancer activity against prostate cancer cells. The extract has blocked the proliferation and movement of prostate tumor cells by modulating the autophagic process and diminishing intracellular ROS concentrations. Moreover, analysis using liquid chromatography-mass spectrometry (LC-MS) of the extract and the cells treated with extract showed that the major compounds present inside prostate cancer cells were terpene derivatives, flavonoid glycosides, and cardenolides indicating possible explanation that those compounds are responsible for anticancer activity on prostate cancer cells.[44]

Pure alcoholic solvent was used to extract the leaves of Calotropis procera. The extract was then evaluated against human colon cancer HCT-116, breast malignant tumor MCF-7 cell lines. The blocking effect of the extract on cell growth was found to be proportional to concentration. Values of IC50 were 50 μg/mL and 55 μg/mL on breast malignancy MCF-7 and colon tumor HCT-116, respectively. The measurement IC50 showed that the extract had potent anticancer activity.[45]

Methanol was used to extract Calotropis procera leaves. The leaves extract was tested on H1299 lung malignant cells was investigated. The article showed that the methanol extract of Calotropis procera leaves exhibits antioxidant and antigrowth properties. The methanol extract of leaves decreased cluster of differentiation 146 (CD146) expression on blood cells after 24 h. The study revealed that Calotropis procera leaf extract exhibits antiproliferative properties by reducing cell viability and possesses the potential to scavenge OH and radicals.[46]

A further investigation assessing the cytotoxicity of Calotropis procera leaf extract revealed significant cytotoxic effects in the brine shrimp mortality bioassay, attributed to the existence of quercetin derivatives.[47]

The anticancer effect of Calotropis procera leaf extract was investigated against different human glioblastoma cell line types. The extract showed potent efficacy in reducing the proliferation of all three glioblastoma multiform (GBM) cell line types, exhibiting heightened cytotoxicity in human glioblastoma U251 GM cells, with an IC50 value of 2.63 ± 0.23 μg/mL, probably by stopping the cell cycle at the G2 to M progression. Nevertheless, the extract demonstrated no harmful impacts in zebrafish eggs, even at doses reaching 1000 μg/mL. The study indicated that Calotropis procera leaf extract is a proposed effective treatment for glioblastoma with minimum side effects.[48]

Water was used to extract the leaves of Calotropis procera. The extract was evaluated for the survival rate of human colon HT-29 cells. The extract showed moderate anticancer activity as shown in IC50 value of 236.87 µg/mL. Moreover, the survival time of cells diminished with increasing concentration of the extract.[49]

Aqueous solvent was used to extract the dried leaves of Calotropis procera. Soxhlet-assisted extraction was employed to obtain a polyphenol-rich extract. The extract was then investigated for cytotoxic activity on human glioblastoma cancer LN-18 cell lines. It is believed that the polyphenol content of the extract may contribute to the anticancer activity on LN-18 cells.[50]

A crude methanolic solvent was used to extract the leaves of Calotropis procera. The extract was then investigated for its anticancer properties on breast cancer MCF-7 cell lines. The crude extract exhibited antigrowth effect on MCF-7 cells.[20,51]

Calotropis procera leaves were extracted with ethanol. The butanol fraction of the extract was then divided by column chromatography to get different elutes. The elutes were then evaluated on liver cancer HEPG2 cell lines using the Sulforhodamine B (SRB) method. Chloroform: methanol 9:1 fraction exhibited significant anticancer activity, reducing the cell growth by half. It was concluded that the flavonoid content of the fraction may be responsible for cytotoxic activity.[52]

Flowers

Methanolic solvent was used to extract the flowers of Calotropis procera using the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay on laryngeal cancer Hep2 and mammalian kidney cell line Vero cells. The extract exhibited complete cytotoxicity against Hep2 cell lines at a dosage of 12.5 mg, while Vero cells showed 83% at the same concentration.[53]

Ethanolic solvent was used to extract the flowers of Calotropis procera. The extract was then examined in a chromatographic evaluation by aqueous and a mixture of aqueous/alcohol solvents. Six compounds were isolated from the extract, which were then tested for antitumor properties on a panel of human cancer cell lines, including breast MCF-7, colon HCT-16, liver HepG-2, and lung A549 cancers. Among the isolated compounds, methyl ferulate was found to be the most active against all cancer cells, with an IC50 ranging from 4.99 to 12.6 µg/mL.[21]

An ethanolic solvent with 70% was used to extract the flowers of Calotropis procera using the MTT assay. The extract was then evaluated for anticancer activity on breast tumor MCF-7 and cervical tumor HeLa cell lines. It was concluded that the flower extract possesses significant anticancer properties on both malignant cells.[54]

Distilled aqueous solvent was used to extract the flowers of Calotropis procera. The extract has been used to synthesize silver nanoparticles that have been incorporated as a gel for use on skin. The formulated nanogel composed of silver nanoparticles has shown anticancer activity on skin cancer A-431 cells. It was concluded that the nanoparticles derived from the shrub are a potential skin cancer candidate to produce skin cancer drugs[55]

Aerial parts

Another study evaluated the effects of Cathepsin L (CTSL) inhibition on cancer cell migration and invasion. SnuCalCpI15, a proprietary derived from the I29 domain of a CTSL-like cysteine protease isolated from the aerial parts of Calotropis procera, was evaluated for its inhibitory activity. The findings showed that SnuCalCpI15 selectively inhibited CTSL in a reversible, slow-binding manner. Its activity was supported by a low inhibitory constant (Ki) of 1.38 ± 0.71 nM. Furthermore, the propeptide was detected within MDA-MB-231 human breast cancer cells, where it suppressed malignant cell migration and invasion.[56]

Ethanolic and water extracts from the aerial parts of Calotropis procera were used to synthesize environmentally friendly (green) nanoparticles containing iron or zinc. The most potent antitumor activity on A-431 human epidermoid malignant cells was demonstrated by zinc nanoparticles made from the aqueous extract, with an IC50 value of 188.97 µg/mL. The result highlights the significant potential of sustainable nanomaterials as anticancer agents.[57]

A summary of cytotoxicity studies on different components of Calotropis procera has been summarized in Table 2.[58-61]

Table 2: Summary of cytotoxic activity of Calotropis procera.
No. Cancer type/cell line Plant part

IC 50*

(µg/mL)

Study type Ref
1 Lung A549 Latex 3.37

In vitro

[58]
2 Cervical HeLa latex 6.45
3 Lung A549 Latex chloroform extract 0.985
4 Brain SF295 Laticifer protein (latex) 0.42 [22]
5 Breast MDA-MB-435 Laticifer protein (latex) 1.36
6 Ovarian Ovcar-8 Protein (latex) 1.2 [38]
7 Colon HT 29 Leaves aqueous extract 236.87 [49]
8 Leukemia K562 Stem ethanol extract 26.8 ± 0.4 [59]
9 Oral KB Root ethanol extract 10 [30]
10 Sarcoma 180 Stem ethyl-acetate extract In vivo [31]
11 Glioblastoma U-251 Leaf methanol extract 2.63 ± 0.23 In vitro [48]
12 Skin A-431 Zn nanoparticles (leaf) 188.97 [57]
13 Breast MCF-7 Leaves ethanol extract 50 [45]
14 Colon HCT-116 55
15 Breast MCF-7 Gold nanoparticles (leaf) 312 [42]
16 Cervical HeLa Whole plant methanol extract 3.1 ± 0.4 [60]
17 Prostate PC3 5.1 ± 0.3
18 Liver HepG-2 Flower ethanol extract 24.50 ± 1.68 [21]
19 Colon COLO 320 Flower ethanol extract 1.4 ± 0.1 [61]

* In vivo study, ± : Standard error means of triplicate values (SEM).

CYTOTOXIC PHYTOCONSTITUENTS

Calotropis procera contains cytotoxic compounds such as cardenolides, flavonoids, lignans, and alkaloids.[62]

Cardenolides

Eleven cardenolides were extracted through fractionation guided by bioassay of the effective chloroform extract of Calotropis procera latex. The antiproliferative properties of all isolated cardenolides from Calotropis procera were investigated using the MTT colorimetric assay on human lung A549 and HeLa cervix cancer cell lines. Calactin showed the highest cytotoxicity of these substances on both cell lines, with IC50 measurements of 0.036 μM for A549 and 0.083 μM for HeLa, respectively. A tentative structure-function connection within these compounds indicates that the doubly connected six-membered cyclic sugar system offers a further positive impact [Figure 2].[58] However, the structure-activity relationship is based on a few compounds. A larger study could solidify the hypothesis.

Doubly linked six-membered ring moiety.[58]
Figure 2:
Doubly linked six-membered ring moiety.[58]

The ethyl acetate fraction was fractioned from the methanolic extract of Calotropis procera root bark during a study. The process of fractionation resulted in the identification of three cardenolides, namely procera A, frugoside, and calotropin. The separated compounds were then tested for cytotoxic effect on lung cancer A549, prostate cancer PC-3, and glioblastoma U373 cell lines. Calotropin has been proven to possess the most active properties among the three compounds on all cancer cell lines, with IC50 values of 0.005 µg/mL on all tested cancer cells.[23]

Methanol and butanol were used to extract the aerial portions of Calotropis procera, while methanol only was used to extract the milky latex of the shrub. The process of extraction resulted in the identification of eight cardenolides. Of the isolated compounds, calotropin and calotoxin were found to possess anticancer effects on breast cancer MDA-MB-231 and human lung A549 malignant cells. The activity of calotoxin was confirmed by the IC50 values, which were found to be 0.046 and 0.057 µg/mL on breast and lung cancer cells, respectively.[63]

Evaluation of Calotropis procera root bark led to the detection of a cardenolide, 2ʺ-oxovoruscharin. The compound was used to hemi-synthesize another cardenolide exhibiting significant cytotoxicity against several cancer cell lines. The hemi-synthesized compound showed considerable cytotoxicity, with IC50 values of 3, 9, 24, 10, and 8 µM against human glioma Hs683, glioblastoma U373, colon HCT-15, colon LoVo, and A549, respectively.[64]

Uzaigenin and calotropagenin, two elements of Calotropis procera, are natural compounds that have exhibited an ability to suppress cancer cells both in vitro and in vivo, with a specific emphasis on mitochondrial activity.[65]

Oxypregnanes

An evaluation of the normal butanol extract fraction from the root bark of Calotropis procera resulted in the identification of a set of novel oxypregnane oligoglycosides. The antiproliferative activity of the normal butanol fraction and extracted chemicals was tested on human lung A549, glioblastoma U373, and prostate PC-3 tumor cell lines. Two substances revealed notable cytotoxicity, with IC50 values between 0.5 and 0.7 µM on U373 and PC-3 cell lines.[25]

Flavonoids

Evaluation of Calotropis procera leaf extract resulted in the separation of 13 compounds. These compounds were evaluated for anticancer effects on brine shrimp. The brine shrimp mortality bioassay test revealed that of the isolated compounds, quercetin, isoharmentin, and azaleatin exhibited cytotoxic effects on brine shrimp with IC50 values of 10, 22, and 21 µg/mL, respectively. The existence of free OH substituents on the A- or B-cycles is likely essential for the antitumor effect of quercetin, because complete methyl substitution of quercetin hydroxyl substituents totally deactivated it. Additionally, 3-etherification entirely removed the cytotoxicity, confirming the significance of the three hydroxyl groups substitution of quercetin for its activity [Figure 3].[47]

Key free hydroxy groups for quercetin cytotoxicity.[47]
Figure 3:
Key free hydroxy groups for quercetin cytotoxicity.[47]

The ethanolic extract of Calotropis procera stems was used to isolate five components. Of these compounds, uzarigenin exhibited moderate cytotoxicity. The findings revealed that uzarigenin reduced the biochemical effect of HT29 and HepG2 cells by 59% and 35%, respectively, at a concentration of 50 µM.[66]

Triterpenes

Root bark of Calotropis procera hexane fraction was used to separate calotroprocerol A, a novel triterpene [Figure 4]. The compound was evaluated for inhibition activity using the MTT assay method on three cancer cell lines. The results revealed that calotroprocerol A had cytotoxic efficacy, with IC50 values of 11.84, 11.84, and 21.98 µg/mL in A549, U373, and PC-3 cell lines, respectively.[67]

Compounds with cytotoxic activity in Calotropis procera.[23,58,63]
Figure 4:
Compounds with cytotoxic activity in Calotropis procera.[23,58,63]

Other compounds

The fruits, flowers, and leaves of Calotropis procera were utilized to extract methyl ferulate. The chemical was assessed for cytotoxic efficacy on MCF-7, HCT-116, HepG-2, and A549 human cancer cell lines.[68] Methyl ferulate demonstrated considerable cytotoxicity, with IC50 values of 12.60 ± 2.0 µg/mL for MCF-7, 6.80 ± 0.46 µg/mL for HCT-116, 4.99 ± 0.60 µg/mL for HepG-2, and 6.03 ± 0.52 µg/mL for A549, respectively.[21]

Compounds with cytotoxic potential isolated from Calotropis procera have been summarized in Table 3, Figure 5 and referenced in table 4.

Table 3: Cytotoxic compounds in Calotropis procera.
No. Compound Cell line type Part used Study type Ref
1 Calotoxin MDA-MB-231 Aerial parts In vitro [63]
A549
A549 Latex [58]
HeLa
2 Calactin A549
HeLa
3 Calactoprocin A549
HeLa
4 Uscharin A549
HeLa
5 Proceraside A A549 Root bark [23]
PC-3
U373
6 Frugoside A549
U373
PC-3
7 Calotropin A549
U373
PC-3
A549 Aerial parts [63]
MDA-MB-231
8 Methyl ferulate MCF-7 Flower [21]
HCT-116
HepG-2
A549
9 Kaempferol 3-O-α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranoside HepG-2 Fruit
10 calotropagenin A549 Leaves
11 Calotroprocerol A A549 Root bark [67]
U373
PC-3
Summary of cytotoxic compounds isolated from different parts of Calotropis procera.[23,58,63,68]
Figure 5:
Summary of cytotoxic compounds isolated from different parts of Calotropis procera.[23,58,63,68]
Table 4: References of anticancer active compounds azalea tin.
No. Compound Reference
1 Calactoprocin [58]
2 Calactin
3 Proceraside A [23]
4 Frugoside
5 Calotropin
6 Calotoxin [63]
7 Calotropagenin [68]

CONCLUSION

Calotropis procera is a medicinal plant with known anticancer, antioxidant, and anti-inflammatory properties that prompted widespread use in traditional remedies. Several experiments conducted in vitro and in vivo illustrated the plant's cytotoxic activity. Extracts from different parts of the plant and isolated phytoconstituents exhibited antitumor properties. MCF-7 (breast), HepG2 (liver), and A549 (lung) are common cell lines against which the plant showed anticancer activity in several studies. Notably, nanoparticles derived from Calotropis procera show promising properties. Nanoparticles obtained from the plant could be used as cancer medications. However, the plant is toxic, and direct contact with the shrub can cause skin irritation and eye complications. Oral intake in high amounts can cause cardiotoxicity. In conclusion, Calotropis procera is a medicinal shrub with a promising cytotoxic activity, which could be used to develop new drugs to treat cancer. Nonetheless, challenges such as the toxicity of the plant towards humans and limited human experiments hinder its applicability. Future work on the plant's toxicity towards humans and nanoparticle efficacy is recommended.

Author contributions

SA: Writing primary draft. HAA: Writing final manuscript. LMA: Revision of manuscript.

Ethical approval

Institutional Review Board approval is not required.

Declaration of patient consent

Patient's consent not required as there are no patients in this study.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

References

  1. , , . Current trends and emerging diagnostic techniques for lung cancer. Biomed Pharmacother. 2018;106:1586-99.
    [CrossRef] [PubMed] [Google Scholar]
  2. , , , , , , et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-63.
    [CrossRef] [PubMed] [Google Scholar]
  3. , , , , , , et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. BMJ Oncol. 2023;2:e000049.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  4. , , , , , , et al. Deep learning in cancer diagnosis and prognosis prediction: A minireview on challenges, recent trends, and future directions. Comput Math Methods Med. 2021;2021:9025470.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  5. , , , , , , et al. Roles of foods and related components: An overview on cancer causatives, and plausible preventions. Appl Food Res. 2025;5:101132.
    [CrossRef] [Google Scholar]
  6. , , , , , . The role of bioactive compounds in natural products extracted from plants in cancer treatment and their mechanisms related to anticancer effects. Oxid Med Cell Longev. 2022;2022:1429869.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  7. , , , , , , et al. Anticancer drug discovery based on natural products: from computational approaches to clinical studies. Biomedicines. 2024;12:201.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  8. , . Apoptosis and cancer: Force awakens, phantom menace, or both? Int Rev Cell Mol Biol. 2018;337:135-52.
    [CrossRef] [PubMed] [Google Scholar]
  9. , , , , , , et al. Natural products as anticancer agents: Current status and future perspectives. Molecules. 2022;27:8367.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  10. , , , , , , et al. Pharmacological profiling of Calotropis procera and Rhazya stricta: Unraveling the antibacterial and anti-cancer potential of chemically active metabolites. J Cancer. 2025;16:12-33.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  11. , , , . Calotropis procera: An Overview of Its Phytochemistry and Pharmacology. IJOD Indian J Drugs. 2013;12:63-69.
    [Google Scholar]
  12. . Evaluation of insecticidal efficacy of Calotropis procera and annona squamosa ethanol extracts against musca domestica. J Biofertil Biopestici. 2010;01.
    [CrossRef] [Google Scholar]
  13. , , , . The biology of Calotropis procera (Aiton) w.T. Trees. 2015;29:311-20.
    [CrossRef] [Google Scholar]
  14. , , , . An overview of the characteristics and potential of Calotropis procera from botanical, ecological, and economic perspectives. Front Plant Sci. 2021;12:690806.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  15. , , , , , , et al. Essential oil of Calotropis procera: comparative chemical profiles, antimicrobial activity, and allelopathic potential on weeds. Molecules. 2020;25:5203.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  16. , , , , , , et al. New insights into the complex mixture of latex cysteine peptidases in Calotropis procera. Int J Biol Macromol. 2013;58:211-9.
    [CrossRef] [PubMed] [Google Scholar]
  17. , . Antiinflammatory efficacy of extracts of latex of Calotropis procera against different mediators of inflammation. Mediators Inflamm. 2005;2005:228-32.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  18. , , , . A review on Calotropis procera its phytochemistry and traditional uses. BigdataAgr. 2020;2:56-8.
    [CrossRef] [Google Scholar]
  19. , . Potential of utilizing Calotropis procera flower biomass as a renewable source of energy. J Phytol. 2010;2:78-83.
    [Google Scholar]
  20. , , . A comprehensive review on the anticancerous activity of arka (Calotropis procera) J Ayurveda Integr Med Sci. 2024;9:241-7.
    [Google Scholar]
  21. , , , , , , et al. Evaluation of antiulcer and cytotoxic potential of the leaf, flower, and fruit extracts of Calotropis procera and isolation of a new lignan glycoside. Evid Based Complement Alternat Med. 2017;2017:8086791.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  22. , , , , , , et al. In vitro cytotoxicity against different human cancer cell lines of laticifer proteins of Calotropis procera (Ait.) R Br. Toxicol In Vitro. 2007;21:1563-73.
    [CrossRef] [PubMed] [Google Scholar]
  23. , , , , , , et al. Proceraside a, a new cardiac glycoside from the root barks of Calotropis procera with in vitro anticancer effects. Nat Prod Res. 2014;28:1322-7.
    [CrossRef] [PubMed] [Google Scholar]
  24. , , , , , . Cytotoxicity assessment of aqueous extract from root barks of Calotropis procera (Ait.) R Br. in human intestinal Caco-2 and mouse neuroblastoma Neuro-2a celllines. J App Pharm Sci 2014
    [Google Scholar]
  25. , , , , , . Calotroposides h–N, new cytotoxic oxypregnane oligoglycosides from the root bark of Calotropis procera. Steroids. 2015;96:63-72.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , , , , et al. Identification of a novel Calotropis procera protein that can suppress tumor growth in breast cancer through the suppression of NF-κB pathway. PLoS One. 2012;7:e48514.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  27. , , , . Bcl2-dependent antineoplastic effects of Calotropis procera root extract against canine mammary tumor cells. Vet Res Forum. 2021;12:197-202.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  28. , , , , . Isolation of dihydroquercetin glycoside from the root bark of Calotropis procera and antioxidant and cytotoxic screening of the crude extracts. JCSN. 2021;46
    [CrossRef] [Google Scholar]
  29. , , . Anti-cancer and anti-oxidative activities of nigerian traditional medicinal plants/recipes. J Complement Med Res. 2019;10:200.
    [CrossRef] [Google Scholar]
  30. , , . In vitro cytotoxicity of extracts and fractions of Calotropis procera (Ait.) roots against human cancer cell lines. Int J Green Pharm. 2010;4:36.
    [Google Scholar]
  31. , , , , , , et al. In vitro and in vivo antiproliferative activity of Calotropis procera stem extracts. An Acad Bras Cienc. 2010;82:407-16.
    [CrossRef] [PubMed] [Google Scholar]
  32. Bankole AA, Thiemann T. Chemistry, biological activities, and uses of calotropis latex. In Reference Series in Phytochemistry 2022, pp. 769-99
  33. , , , , , , et al. In vivo growth inhibition of sarcoma 180 by latex proteins from Calotropis procera. Naunyn Schmiedebergs Arch Pharmacol. 2010;382:139-49.
    [CrossRef] [PubMed] [Google Scholar]
  34. , , , , , , et al. Insights on the phytochemical profile (cyclopeptides) and biological activities of Calotropis procera latex organic fractions. ScientificWorldJournal. 2013;2013:615454.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  35. , , , , , , et al. Anticancer effects of Calotropis procera latex extract in mcf-7 breast cancer cells. Phcog Mag. 2020;16:550.
    [CrossRef] [Google Scholar]
  36. . Calotropis procera: A promising candidate in cancer pharmacology. JPMS. 2024;13:29-36.
    [CrossRef] [Google Scholar]
  37. , , . Anti-inflammatory and antioxidant effect of methanol extract of latex of Calotropis procera in rat model of colorectal cancer. J Ethnopharmacol. 2022;296:115503.
    [CrossRef] [PubMed] [Google Scholar]
  38. , , , , , , et al. Cytotoxicity against tumor cell lines and anti-inflammatory properties of chitinases from Calotropis procera latex. Naunyn Schmiedebergs Arch Pharmacol. 2017;390:1005-13.
    [CrossRef] [PubMed] [Google Scholar]
  39. , , , , , , et al. An updated pharmacological insight into calotropin as a potential therapeutic agent in cancer. Front Pharmacol. 2023;14:1160616.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  40. , , , . In vitro pharmacological evaluation of Methanolic leaf extract of Calotropis procera for antifungal and anti-breast cancer activities. Toxicol Res (Camb). 2024;13:tfae186.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  41. , , . Evaluation of the cytotoxic effects of the colchicine compound isolated from the leaves of Calotropis procera (Ait) against MCF-7 and SK-GT-4 cancer cell lines. Baghdad Science Journal. 2023;20:1590.
    [CrossRef] [Google Scholar]
  42. , . Cytotoxicity property of biologically synthesized gold nanoparticles from aqueous leaf extract of Calotropis procera (Apple of Sodom) on MCF-7 cell line. BJMMR. 2016;15:1-8.
    [CrossRef] [Google Scholar]
  43. , , , , , . Anticancer and antibacterial activity of Calotropis procera leaf extract. J Basic Appl Sci Res. 2017;12:18-25.
    [Google Scholar]
  44. , , , , , , et al. Calotropis procera extract inhibits prostate cancer through regulation of autophagy. J Cell Mol Med. 2024;28:e18050.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  45. , , , , , , et al. Potential anticancer properties of Calotropis procera: An investigation on breast and colon cancer cells. Heliyon. 2023;9:e16706.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  46. , , , , , , et al. Anti-proliferative, antioxidant effects of methanol extract of Calotropis procera leaf on lung cancer cells (H1299) and its ameliorative effect on expression of CD146 on blood cells. Clin Phytosci. 2021;7:51.
    [CrossRef] [Google Scholar]
  47. , , , . Antioxidant and cytotoxic flavonols from Calotropis procera. Z Naturforsch C J Biosci. 2011;66:547-54.
    [CrossRef] [PubMed] [Google Scholar]
  48. , , , , . Calotropis procera: A double edged sword against glioblastoma, inhibiting glioblastoma cell line growth by targeting histone deacetylases (HDAC) and angiogenesis. Heliyon. 2024;10:e24406.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  49. , , , , . Identification of phytochemical, antioxidant, anticancer and antimicrobial potential of Calotropis procera leaf aqueous extract. Sci Rep. 2023;13:14716.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  50. , , , , , , et al. An electrochemical perspective assay for anticancer activity of Calotropis procera against glioblastoma cell line (LN-18) using carbon nanotubes- graphene nano- conglomerate as a podium. Adv Mater Lett. 2016;7:1003-9.
    [CrossRef] [Google Scholar]
  51. , , . Study of the cytotoxic effect of Calotropisprocera on Breast Cancer Cell Line T47D in Vitro: A Traditional Remedy. Inter J Sci Innov. 2019;7:107-12.
    [Google Scholar]
  52. , , . in vitro cytotoxicity of chromatographic elutes of Calotropis procera (AIT.) R BR leaves against human hepatoma cell line (HEPG2) Ind Dru. 2016;53:48-52.
    [Google Scholar]
  53. Prabha MR, Vasantha K. Antioxidant, cytotoxicity and polyphenolic content of Calotropis procera (Ait.) R. Br. Flowers, https://api.semanticscholar.org/CorpusID:43172388.
  54. , , , , . In vitro cytotoxic activities of Calotropis procera latex and flower extracts against MCF-7 and HeLa cell line cultures. Int J Pharm Pharm Sci. 2011;4:66-70.
    [Google Scholar]
  55. , , , , , . Nanomedicinary evaluation of Calotropis procera mediated silver nanoparticle on skin cancer cell line for microbes-front line analysis. J Mol Struct. 2021;1235:130237.
    [CrossRef] [Google Scholar]
  56. , , , , , , et al. Cysteine protease I29 propeptide from Calotropis procera R Br As a potent cathepsin L inhibitor and its suppressive activity in breast cancer metastasis. Sci Rep. 2024;14:23218.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  57. , , , . Biogenic synthesis and physicochemical characterization of metal nanoparticles based on Calotropis procera as promising sustainable materials against skin cancer. Sci Rep. 2024;14:25154.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  58. , , , , , , et al. Cytotoxic cardenolides from the latex of Calotropis procera. Bioorg Med Chem Lett. 2015;25:4615-20.
    [CrossRef] [PubMed] [Google Scholar]
  59. , , , , , , et al. Evaluation of the cytotoxicity of products obtained from Calotropis procera (Apocynaceae) RSD. 2020;9:e4391210723.
    [CrossRef] [Google Scholar]
  60. , , , , , , et al. In Vitro biological and GC-MS analysis of whole plant Calotropis procera. J Chem. 2024;2024:1-23.
    [Google Scholar]
  61. , , , , , . Āyurvedic herbal drugs with possible cytostatic activity. J Ethnopharmacol. 1995;47:75-84.
    [CrossRef] [PubMed] [Google Scholar]
  62. , , , , . A review on phytochemical constituents and pharmacological potential of Calotropis procera. RSC Adv. 2021;11:35854-78.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  63. , , , . Anticancer cardenolides from the aerial parts of Calotropis procera. Z Naturforsch C J Biosci. 2021;76:243-50.
    [CrossRef] [PubMed] [Google Scholar]
  64. , , , , , , et al. Identification of a novel cardenolide (2‘ ‘-Oxovoruscharin) from Calotropis procera and the hemisynthesis of novel derivatives displaying potent In Vitro antitumor activities and high In Vivo tolerance:  Structure−activity relationship analyses. J Med Chem. 2005;48:849-56.
    [CrossRef] [PubMed] [Google Scholar]
  65. , , , , . Calotropis procera accumulates uzarigenin and calotropagenin in response to environmental lighting and drought. Saudi J Biol Sci. 2023;30:103622.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  66. , , , , . Secondary metabolites from Calotropis procera (Aiton) Phytochemistry Letters. 2010;3:212-6.
    [CrossRef] [Google Scholar]
  67. , , , , , , et al. New ursane-type triterpenes from the root bark of Calotropis procera. Phytochem Lett. 2012;5:490-5.
    [CrossRef] [Google Scholar]
  68. , . Rapid identification of calotropagenin glycosides using high‐performance liquid chromatography electrospray ionisation tandem mass spectrometry. Phytochem Anal. 2012;23:117-25.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections